<?xml version="1.0" encoding="ISO-8859-1"?>
<!-- generator="FeedCreator 1.7.2" -->
<rdf:RDF
    xmlns="http://purl.org/rss/1.0/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
    xmlns:dc="http://purl.org/dc/elements/1.1/">
    <channel rdf:about="http://www.hormone-facts.com/endocrine-hormone-news-rss/thyroxine/">
        <title>Hormone Facts</title>
        <description>'Thyroxine'</description>
        <link>http://www.hormone-facts.com/thyroxine/</link>
       <dc:date>2008-11-21T14:02:11+01:00</dc:date>
        <items>
            <rdf:Seq>
                <rdf:li rdf:resource="http://www.hormone-facts.com/endocrine-hormone-news/thyroxine/#epa-advisers-seek-perchlorate-review"/>
                <rdf:li rdf:resource="http://www.hormone-facts.com/endocrine-hormone-news/thyroxine/#pharmac-approves-eltroxin-alternative"/>
            </rdf:Seq>
        </items>
    </channel>
    <item rdf:about="http://www.hormone-facts.com/endocrine-hormone-news/thyroxine/#epa-advisers-seek-perchlorate-review">
        <dc:format>text/html</dc:format>
        <title>EPA Advisers Seek Perchlorate Review</title>
        <link>http://www.hormone-facts.com/endocrine-hormone-news/thyroxine/#epa-advisers-seek-perchlorate-review</link>
        <description>The Environmental Protection Agency's scientific advisers have warned the agency that it should delay final action on its decision not to set a federal drinking-water standard for perchlorate, a chemical in rocket fuel, because the computer model underlying the decision may have flaws.        </description>
    </item>
    <item rdf:about="http://www.hormone-facts.com/endocrine-hormone-news/thyroxine/#pharmac-approves-eltroxin-alternative">
        <dc:format>text/html</dc:format>
        <title>Pharmac approves Eltroxin alternative</title>
        <link>http://www.hormone-facts.com/endocrine-hormone-news/thyroxine/#pharmac-approves-eltroxin-alternative</link>
        <description>After public pressure Pharmac has approved an alternative to the thyroid drug, Eltroxin. Hundreds of patients who were recently switched to the drug reported side effects, some severe.</description>
    </item>
</rdf:RDF>
